Double maintains 4 strategies that include CRL - Charles River Laboratories International, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 67.88% | $48.46M | 0.69% |
IBB | 61.52% | $5.92B | 0.45% |
BBH | 59.13% | $368.79M | 0.35% |
RSPH | 58.48% | $790.11M | 0.4% |
FXH | 57.02% | $960.13M | 0.62% |
SMOT | 56.87% | $412.48M | 0.49% |
RZV | 55.88% | $200.41M | 0.35% |
GSSC | 55.83% | $512.57M | 0.2% |
IJR | 55.68% | $78.01B | 0.06% |
VIOV | 55.65% | $1.21B | 0.1% |
PBE | 55.63% | $233.11M | 0.58% |
EES | 55.57% | $574.87M | 0.38% |
IJS | 55.52% | $6.40B | 0.18% |
EZM | 55.51% | $743.75M | 0.38% |
FNDA | 55.51% | $8.51B | 0.25% |
VIOO | 55.47% | $2.73B | 0.07% |
SPSM | 55.33% | $10.91B | 0.03% |
NUSC | 55.11% | $1.11B | 0.31% |
IWM | 54.97% | $64.21B | 0.19% |
VTWO | 54.95% | $10.91B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -33.25% | $404.97M | 1.43% |
VIXY | -29.96% | $195.31M | 0.85% |
TAIL | -26.55% | $86.92M | 0.59% |
ULST | -12.65% | $587.03M | 0.2% |
TPMN | -11.94% | $33.51M | 0.65% |
DBE | -10.17% | $54.58M | 0.77% |
TFLO | -10.12% | $6.78B | 0.15% |
USCI | -10.05% | $236.09M | 1.07% |
BNO | -10.01% | $95.40M | 1% |
UGA | -9.87% | $88.11M | 0.97% |
USL | -9.87% | $46.60M | 0.85% |
CTA | -9.53% | $963.19M | 0.76% |
USO | -9.47% | $1.02B | 0.6% |
OILK | -9.39% | $66.42M | 0.69% |
EQLS | -9.16% | $4.77M | 1% |
COMT | -9.00% | $674.22M | 0.48% |
DBO | -8.72% | $197.54M | 0.77% |
SGOV | -8.65% | $39.39B | 0.09% |
XHLF | -8.43% | $1.06B | 0.03% |
PDBC | -7.91% | $4.82B | 0.59% |
Current Value
$150.811 Year Return
Current Value
$150.811 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IQV | 70.51% | $31.08B | -29.16% | 0.00% |
MEDP | 59.65% | $9.28B | -23.44% | 0.00% |
RVTY | 54.37% | $12.71B | +2.45% | 0.26% |
VSH | 53.55% | $2.16B | -29.40% | 2.53% |
TECH | 53.46% | $9.27B | -15.53% | 0.55% |
POWI | 51.93% | $2.87B | -28.54% | 1.55% |
FELE | 51.83% | $4.30B | -11.01% | 1.08% |
QLYS | 51.38% | $4.59B | -24.72% | 0.00% |
UFPI | 50.99% | $6.51B | -10.73% | 1.26% |
TRMB | 50.71% | $16.14B | +3.93% | 0.00% |
SLAB | 50.69% | $3.66B | -20.71% | 0.00% |
USPH | 50.57% | $1.10B | -35.48% | 2.46% |
AZTA | 50.39% | $1.58B | -41.33% | 0.00% |
KMT | 49.99% | $1.65B | -12.63% | 3.78% |
IOSP | 49.31% | $2.36B | -25.01% | 1.63% |
TXT | 49.20% | $13.12B | -24.21% | 0.11% |
KN | 49.13% | $1.33B | -5.82% | 0.00% |
FTRE | 48.76% | $681.01M | -81.13% | 0.00% |
MSM | 48.63% | $4.34B | -19.05% | 4.34% |
CVBF | 48.43% | $2.58B | +5.91% | 4.37% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -17.71% | $23.69B | +24.42% | 1.08% |
HIHO | -11.28% | $8.12M | -11.51% | 6.50% |
PM | -11.09% | $246.80B | +73.59% | 3.38% |
PULM | -10.75% | $24.32M | +282.76% | 0.00% |
CME | -9.66% | $95.61B | +25.13% | 3.98% |
ZCMD | -8.44% | $32.28M | -3.40% | 0.00% |
FTNT | -8.29% | $74.02B | +41.93% | 0.00% |
EQNR | -8.25% | $72.33B | +2.54% | 5.23% |
TTE | -6.62% | $135.71B | -7.24% | 5.25% |
DKL | -6.14% | $2.32B | +6.42% | 10.03% |
PG | -6.14% | $399.61B | +6.13% | 2.36% |
VSTA | -6.05% | $363.18M | +12.97% | 0.00% |
MO | -5.64% | $101.47B | +38.87% | 6.74% |
PAYO | -5.63% | $2.63B | +49.49% | 0.00% |
LITB | -5.07% | $36.77M | -56.14% | 0.00% |
LFVN | -5.05% | $183.00M | +128.17% | 1.05% |
MVO | -4.74% | $62.10M | -50.68% | 23.99% |
CPNG | -4.71% | $39.59B | +20.49% | 0.00% |
PACS | -4.48% | $1.74B | -46.48% | 0.00% |
K | -4.37% | $28.48B | +44.57% | 2.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CPSH | 0.02% | $23.10M | -10.67% | 0.00% |
MNOV | 0.05% | $71.61M | -0.68% | 0.00% |
CTRE | 0.08% | $5.36B | +17.90% | 4.21% |
TEVA | -0.09% | $17.61B | +10.50% | 0.00% |
CATO | -0.11% | $68.39M | -38.79% | 10.15% |
TMUS | 0.12% | $304.51B | +63.96% | 1.15% |
WELL | 0.12% | $98.25B | +66.55% | 1.71% |
BYRN | 0.12% | $381.37M | +15.34% | 0.00% |
LTM | -0.14% | $9.45B | -100.00% | <0.01% |
AEP | 0.22% | $58.35B | +29.22% | 3.34% |
PPC | -0.24% | $12.93B | +57.95% | 0.00% |
GIS | 0.25% | $32.74B | -14.74% | 3.99% |
PHYS | 0.26% | - | - | 0.00% |
LOAR | -0.28% | $6.61B | +152.32% | 0.00% |
EXC | -0.31% | $46.52B | +23.77% | 3.35% |
AMT | 0.36% | $101.72B | +12.74% | 2.94% |
STG | -0.46% | $28.45M | -43.90% | 0.00% |
FENG | 0.49% | $12.76M | +21.99% | 0.00% |
CYCN | 0.65% | $6.78M | -18.57% | 0.00% |
DAO | 0.74% | $238.29M | +83.86% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTG | 0.01% | $1.82B | 0.07% |
TBIL | 0.09% | $5.32B | 0.15% |
KRBN | 0.10% | $173.49M | 0.85% |
GLDM | 0.11% | $13.04B | 0.1% |
SOYB | 0.16% | $25.81M | 0.22% |
SGOL | 0.23% | $4.74B | 0.17% |
BAR | 0.27% | $1.03B | 0.1749% |
FXY | -0.28% | $546.19M | 0.4% |
IAU | 0.32% | $41.95B | 0.25% |
IBD | -0.38% | $381.57M | 0.44% |
AAAU | 0.47% | $1.28B | 0.18% |
GLD | 0.56% | $92.15B | 0.4% |
PZA | 0.59% | $2.97B | 0.28% |
SHYD | 0.68% | $319.64M | 0.35% |
OUNZ | 0.68% | $1.48B | 0.25% |
CGSM | 0.72% | $636.53M | 0.25% |
BSMR | -0.75% | $232.31M | 0.18% |
BOXX | -0.75% | $5.72B | 0.1949% |
WEAT | -0.78% | $113.78M | 0.28% |
UTWO | 0.80% | $377.34M | 0.15% |
Yahoo
Charles River and Valo Health identify a potential therapeutic for lupus using their combined offering, Logica.
MarketWatch
Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors
Yahoo
WILMINGTON, Mass. & CAMBRIDGE, Mass., March 25, 2025--Charles River and Valo Health announce the identification of an advanceable product candidate for treatment of lupus and other autoimmune diseases.
Yahoo
We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics Market According to a […]
MarketWatch
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
Yahoo
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.